SPINEMarketGroup

Spine Industry News

2024

We are proud to announce that GLOBAL biomedica will be Sponsor of SPINEMarketGroup in 2024!

By

Thank you GLOBAL biomedica! On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site again in 2024 through your PLATINUM sponsorship. About GLOBAL biomedica GLOBAL biomedica is manufacturer of orthopedic titanium implants, extended by designing and constructing in collaboration with leading experts in this field, using innovative and high […]

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

By

AUDUBON, Pa., Jan. 10, 2024 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2023. The company anticipates fourth quarter 2023 sales of approximately $615.5 million, an increase of 124.2 percent over the fourth quarter 2022 […]

3Spine Announces Completion of FDA Clinical Trial Enrollment Achieving 325 Surgeries in 2023

By

CHATTANOOGA, Tenn., Jan. 10, 2024 /PRNewswire/ — 3Spine, Inc., a medical device company developing a transformational alternative to lumbar spinal fusion, today announced achievement of US clinical trial enrollment, with 151 completed MOTUS lumbar total joint replacement surgeries and 174 real-world posterior lumbar fusions as of December 2023. The company enrolled a larger fusion cohort in an adaptive […]

Providence Medical Technology Announces FDA Clearance of CAVUX® FFS-LX Lumbar Facet Fixation System for 1- and 2-Level Lumbar Spinal Fusion

By

PLEASANTON, Calif., Jan. 10, 2024 /PRNewswire/ — Providence Medical Technology, Inc. (PMT), a medical device innovator focused on improving surgical outcomes for high-risk spine surgery patients, announced that the U.S. Food and Drug Administration (FDA) has cleared its CAVUX® FFS-LX: Lumbar Facet Fixation System for use in lumbar spinal fusion surgery.  CAVUX® FFS-LX is a novel integrated cage and screw […]

Revolutionizing Spinal Alignment: AI-Enhanced Surgical Planning Software and Titanium Rods Tailored to Six Unique Patient Profiles

By

In the ever-evolving field of spinal health, Spinal Alignment Solutions (SAS) emerged as a groundbreaking company dedicated to providing cutting-edge alignment solutions for the degenerative lumbar spine. Founded on more than 12 years of extensive research by renowned experts Renaud Lafage, Leighton LaPierre, and Brandon B. Arthurs, PE, SAS introduces a paradigm shift in surgical […]

Zavation Introduces 2-Screw ALIF Plating System–Z-Span

By

FLOWOOD, Miss., Jan. 9, 2024 /PRNewswire/ — Zavation Medical Products (“Zavation” or the “Company”), an innovative designer and manufacturer of high-quality spinal implants, instruments, MIS procedural kits, and biologics headquartered in Flowood, MS, announced this year the first commercial implantation of the Z-Span 2-Screw ALIF Plating System, completed in St. Louis, Missouri by Dr. Chris Reeves. Geared towards simplifying and optimizing […]

Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results

By

LEWISVILLE, Texas–(BUSINESS WIRE)– Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced preliminary unaudited fourth quarter 2023 net sales of approximately $200.3 million, an increase of 63.8% on a reported basis and 62.8% on a constant currency basis versus fourth quarter 2022. For the full year 2023, preliminary unaudited net sales were […]

RTI Surgical Announces Agreement to Acquire Cook Biotech from Cook Group

By

ALACHUA, Fla., Jan. 8, 2024 /PRNewswire/ — RTI Surgical, an industry leading contract development and manufacturing organization (CDMO), serving the regenerative medicine industry, announced today that it has signed a definitive agreement to acquire Cook Biotech Incorporated, a leader in advanced tissue-repair products from biomaterials, headquartered in West Lafayette, Indiana. With the acquisition of Cook Biotech, RTI Surgical […]

Compelling Clinical Data Released for Carlsmed’s aprevo® Technology

By

CARLSBAD, Calif.–(BUSINESS WIRE)–Carlsmed announced today that new clinical data on its aprevo® technology has been published in the Global Spine Journal. This landmark study of a patient-matched cohort concluded that the use of aprevo®personalized interbody devices enables a significant improvement in achieving alignment. The study measured the difference in pelvic incidence (PI) and lumbar lordosis (LL), […]

ATEC Announces Record Preliminary Revenue Results for 2023 and 2024 Revenue Guidance

By

CARLSBAD, Calif.–(BUSINESS WIRE)– Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary revenue results for the fourth quarter and full-year ended December 31, 2023, and provided revenue guidance for full-year 2024. Preliminary total revenue grew approximately 37% in the full-year 2023. The continued strong […]

Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan

By

BROOMFIELD, CO, Jan. 08, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that it has executed a strategic partnership agreement solidifying the previously signed non-binding Letter […]

Sacrix Provides Safe Alternative to Risky Revision Spine Surgery, Publishing Groundbreaking Results in Renowned Spine Journal

By

BURLINGTON, Mass., Jan. 6, 2024 /PRNewswire-PRWeb/ –Sacrix, a pioneer medical device company in outpatient spine surgery solutions, proudly unveils a novel Less Exposure Spine Surgery (LESS) technique that helped patients avoid major and risky revision corrective spine surgery. The clinical results were summarized in a research paper authored by Board-certified Orthopedic Spine surgeons and published through a […]

Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer

By

LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that effective immediately, Massimo Calafiore has assumed the role of President and Chief Executive Officer (CEO) and as a member of the Orthofix Board of Directors. In conjunction with Mr. Calafiore stepping into his role as CEO, the Company […]

We are proud to announce that Centinel Spine will be Sponsor of SPINEMarketGroup again in 2024!

By

Thank you Centinel Spine! On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site again in 2024 through your PLATINUM sponsorship! About Centinel Spine, LLC Centinel Spine®, LLC is the leading global medical device company addressing cervical and lumbar spinal disease with the most clinically-proven total disc replacement (TDR) […]

Eminent Spine’s 3D Titanium Anterior Lumbar Stand-Alone System Usage Report and Clinical Study

By

Plano, TX, January 04, 2024 –(PR.com)– Eminent Spine received 510(k) approval of their 3D Titanium Anterior Lumbar Interbody Fusion Stand-Alone System in October of 2022. Since then, Eminent Spine has had a total of 40 3D Titanium ALIF Stand-Alone implants used in procedures in patients who were candidates for an Anterior Lumbar Interbody Fusion. The implants also […]

We are proud to announce that Rudischhauser Surgical Instruments and Implants Manufacturing will be Sponsor of SPINEMarketGroup again in 2024!

By

Thank you Rudischhauser Surgical Instruments and Implants Manufacturing!  On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site again in 2024 through your PLATINUM sponsorship. About Rudischhauser Surgical Instruments and Implants Manufacturing Your partner and OE-Manufacturer of superior instruments, implants and complete set configurations for spinal, orthopaedic and trauma […]

Exciting FDA-Approved Products in the Pipeline for 2024: A Glimpse into the Dynamic Landscape of American Companies

By

With numerous FDA approvals, 2023 has proven to be a landmark year that paves the way for groundbreaking products. As we move into 2024, the spotlight is on American companies, particularly trailblazers like Eminent Spine and Astura Medical, which have been spearheading the approval process and already have captivating portfolios. Eminent Spine, a leading figure […]

LEM Surgical AG Secures CHF 22 Million in Series B Funding to Ready Robotic System for FDA Submission

By

BERN, Switzerland, January 4, 2024 (Newswire.com) – LEM Surgical AG, an innovative surgical robotics company headquartered in Bern, Switzerland, announces the successful completion of its Series B funding, securing CHF 22 million. The round, which was strongly oversubscribed, reflects the strong investors’ confidence in LEM Surgical’s differentiated approach. This substantial funding boost is attributed to the […]

Cerapedics Files Final Module of the PMA Application for FDA Approval of a new P-15 Peptide Enhanced Bone Graft for Lumbar Spine Fusion

By

WESTMINSTER, Colo., Jan. 4, 2024 /PRNewswire/ — Cerapedics Inc., a commercial-stage orthopedics company dedicated to redefining the standard of care for bone repair, today announced that it has filed the final module in the Pre-Market Approval (PMA) application with the U.S. Food and Drug Administration (FDA) for its investigational P-15 Peptide Enhanced Bone Graft. Cerapedics was able […]

Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2

By

KEELE, England, Jan. 4, 2024 /PRNewswire/ — Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft tissue, is pleased to announce that its investee company, Renovos Biologics (Renovos), has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA) for its lead product, […]